Today’s Research Reports on Trending Tickers: Tandem Diabetes Care and NuVasive

NEW YORK, NY / ACCESSWIRE / July 31, 2018 / U.S. markets continued to drop on Monday, as tech sector close in the red weighed by majority of the FAANG (Facebook, Apple, Amazon, Netflix and Google parent Alphabet) stocks. The Dow Jones Industrial Average fell 0.57 percent to close at 25,306.83, while the S&P 500 Index was down 0.58 percent to close at 2,802.60. The Nasdaq Composite Index declined 1.39 percent to close at 7,630.00.

“The market is punishing companies that don’t beat on revenue or earnings, or which give a bad outlook. You need to win on all three to do well, and if you miss, like Facebook did, you get pummeled,” said director of global market research at Boston Partners, Michael Mullaney.

RDI Initiates Coverage on:

Tandem Diabetes Care, Inc.
https://rdinvesting.com/news/?ticker=TNDM

NuVasive, Inc.
https://rdinvesting.com/news/?ticker=NUVA

Tandem Diabetes Care’s stock moved 2.97% lower Monday, to close the day at $24.84. The stock recorded a trading volume of 1,840,930 shares, which was below its three months average volume of 2,593,415 shares. In the last year, Tandem Diabetes Care’s shares have traded in a range of 2.14 – 28.90. The share price has gained 1060.75% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $23.16 is above its 200-day moving average of $10.54. Shares of Tandem Diabetes Care have gained roughly 12.81 percent in the past month and are up 952.54 percent year-to-date.

Access RDI’s Tandem Diabetes Care, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TNDM

On Monday, shares of NuVasive recorded a trading volume of 1,448,100 shares, which was above the three months average volume of 596,164 shares. The stock ended the day 6.02% higher at $57.22. The share price has fallen 16.73% from its 52 week high with a 52 week trading range of 44.62 – 68.72. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $53.76 is above its 200-day moving average of $51.53. Shares of the company are trading at a Price to Earnings ratio of 71.35. Shares of NuVasive have gained roughly 9.79 percent in the past month and are down 2.17 percent year-to-date.

Access RDI’s NuVasive, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NUVA

Our Actionable Research on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) and NuVasive, Inc. (NASDAQ:NUVA) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507500